About Us
About hVIVO
Leadership Team
Our Companies
History
Services
Human Challenge Trials
RSV
Influenza
COVID-19
HRV
Malaria
Asthma & COPD
hMPV
Laboratory Services
Clinical Trial Recruitment
Clinical Trial Site Services
Vaccine Phase II-III Trials
Respiratory Clinical Trials
Specialised Renal and Hepatic Impairment Trials
Articles & Research
News & Media
Regulatory News
Media Coverage
Media Press Kit
Media Library
Events
Investors
Investors
Regulatory News & Email Alerts
Results Centre
Share Price Information
Events & Presentations
ESG
AIM Rule 26
Advisors
Documents
Corporate Governance
Volunteers
Careers
Contact Us
Contact Us
Articles & Research
from hVIVO
Article Types Filter
Article Types Filter
Blog
Presentation
Article
Scientific Paper
Factsheet
Abstract
Case Study
Article Count
1 - 10 of 80 posts
Blog
15 Jul 2025
An introduction to participant recruitment in clinical trials
Participant recruitment in clinical trials is more than a formality; it plays a crucial role in the success of medical research. In this short guide, we explore what participant recruitment...
Read more
Article
09 Jul 2025
A New Era in Respiratory Vaccines: The modRNA Breakthrough and the Power of Human Challenge Trials
Executive Summary As respiratory vaccines continue to impose significant burdens on healthcare systems around the world, vaccine development has entered a transformative era. This white paper explores the history of...
Read more
Factsheet
09 Jul 2025
hLAB Corporate Factsheet
View Link
Abstract
01 Jul 2025
A phase (Ph) 0/Ia study of brigimadlin concentration in brain tissue and a nonrandomized, open-label, dose escalation study of brigimadlin in combination with radiotherapy (RT) in patients (pts) with newly diagnosed glioblastoma (GBM).
View Link
Abstract
01 Jul 2025
A phase I dose escalation study of the LRP5 antagonist BI 905681 in patients with advanced and metastatic solid tumors
View Link
Abstract
01 Jul 2025
HER2-Selective Tyrosine Kinase Inhibitor, Zongertinib (BI 1810631), in Patients With Advanced/Metastatic Solid Tumors With HER2 Alterations: A Phase Ia Dose-Escalation Study
View Link
Abstract
01 Jul 2025
Safety, pharmacokinetics, and pharmacodynamics of AS-1763, a highly selective, orally bioavailable, non-covalent BTK inhibitor, in healthy volunteers (Abstract No. CT137)
View Link
Scientific Paper
01 Jul 2025
Safety, pharmacokinetics, and pharmacodynamics of sofnobrutinib, a novel non-covalent BTK inhibitor, in healthy subjects: First-in-human phase I study
View Link
Factsheet
17 Jun 2025
Human Challenge Trial Factsheet
hVIVO is an early phase full-service Contract Research Organisation (CRO) and the global leader in human challenge trials. The Company delivers end-to-end clinical development services to a diverse and expanding...
View Link
Factsheet
19 May 2025
Recruitment Factsheet
View Link
Article Pagination
1
2
3
…
7
8
Next »
Articles Per Page
Articles Per Page
8
10
16
24
32
Stay connected
Sign up to our emails and follow us on social media to keep up to date with hVIVO.
Comments
By clicking Sign Up you're confirming that you agree with our
Privacy Policy
.
angle-down
meetup
chevron-down
arrow-up